| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_846e2fd4a9b65f867d28c137ec0247dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ce168248b35904429ecd015f0cf534f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-35 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077 |
| filingDate |
2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd670dbb822992cfaa5d9257056e7676 |
| publicationDate |
2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011293577-A1 |
| titleOfInvention |
Therapeutic Methods Using Adipose Tissue-Derived Cell Suspensions Comprising Adipocytes |
| abstract |
Provided herein is a use of an adipose tissue-derived cell suspension which comprises adipocytes for the preparation of a pharmaceutical composition for use in the treatment of an inflammatory disorder, a cartilage or bone disorder and/or the alleviation of pain associated with an inflammatory disorder in a mammalian subject. Also provided herein is a method of treating an inflammatory disorder, a cartilage or bone disorder or alleviating pain associated with an inflammatory disorder in a mammalian subject, comprising administering to the subject a pharmaceutical composition which comprises: (i) an adipose tissue-derived cell suspension which comprises adipocytes; or (ii) a cell-free extract which is prepared from an adipose tissue-derived cell suspension, wherein the adipose tissue-derived cell suspension comprises adipocytes, together with a pharmaceutically-acceptable carrier or diluent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022116983-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20140129184-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102159844-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3052943-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106255884-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9192695-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104203257-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2746915-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2818173-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11229725-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10568990-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9814803-B2 |
| priorityDate |
2008-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |